BOLD (STOCKS)
Boundless Bio, Inc. Common Stock
$1.240000
+0.110000 (+9.73%)
Prev close: $1.130000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Zachary D. Hornby
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $27.00M
- Employees
- 64
- P/E (TTM)
- -0.46
- P/B (TTM)
- 0.26
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
4
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.58 | $-0.53 | -0.0496 | -9.35% |
|
Sep 2025 (Q3)
|
$-0.62 | $-0.59 | -0.0258 | -4.34% |
|
Jun 2025 (Q2)
|
$-0.70 | $-0.66 | -0.0370 | -5.58% |
|
Mar 2025 (Q1)
|
$-0.71 | $-0.75 | +0.0397 | +5.30% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $5.36M |
| Operating Expenses | $63.55M |
| Depreciation and Amortization | $1.30M |
| Research and Development | $44.85M |
| Other Operating Expenses | $17.41M |
| Operating Income/Loss | -$63.55M |
| Income/Loss From Continuing Operations After Tax | -$58.20M |
| Income/Loss From Continuing Operations Before Tax | -$58.20M |
| Income Tax Expense/Benefit | $0.00 |
| Income Tax Expense/Benefit, Current | $0.00 |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$58.20M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$58.20M |
| Net Income/Loss Available To Common Stockholders, Basic | -$58.20M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.60 |
| Diluted Earnings Per Share | -$2.60 |
| Basic Average Shares | 22,360,000 |
| Diluted Average Shares | 22,360,000 |
| Assets | $157.06M |
| Current Assets | $109.61M |
| Cash | $107.60M |
| Other Current Assets | $2.01M |
| Noncurrent Assets | $47.45M |
| Fixed Assets | $3.22M |
| Other Non-current Assets | $44.23M |
| Liabilities | $58.41M |
| Current Liabilities | $12.54M |
| Accounts Payable | $1.49M |
| Wages | $2.64M |
| Other Current Liabilities | $8.40M |
| Noncurrent Liabilities | $45.87M |
| Equity | $98.65M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $98.65M |
| Liabilities And Equity | $157.06M |
| Net Cash Flow From Operating Activities | -$46.66M |
| Net Cash Flow From Operating Activities, Continuing | -$46.66M |
| Net Cash Flow From Investing Activities | $37.80M |
| Net Cash Flow From Investing Activities, Continuing | $37.80M |
| Net Cash Flow From Financing Activities | $141.00K |
| Net Cash Flow From Financing Activities, Continuing | $141.00K |
| Net Cash Flow | -$8.72M |
| Net Cash Flow, Continuing | -$8.72M |
| Comprehensive Income/Loss | -$58.25M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$58.25M |
| Other Comprehensive Income/Loss | -$57.00K |